VitaNova Life Sciences (VNOV) EBIT Growth (3y) (2020 - 2026)
VitaNova Life Sciences (VNOV) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 29.94% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 26.79% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -3.82% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 1.32% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 85.70% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 20.42% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -1.40% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 66.97% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 6.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 66.97% |
| Oct 31, 2025 | 182.17% |
| Jul 31, 2025 | -158.14% |
| Apr 30, 2025 | 248.63% |
| Jan 31, 2025 | 65.04% |
| Oct 31, 2024 | 59.89% |
| Jul 31, 2024 | -63.00% |
| Apr 30, 2024 | 123.09% |
| Jan 31, 2024 | 59.42% |
| Oct 31, 2023 | 10.92% |
| Jul 31, 2023 | -29.18% |
| Apr 30, 2023 | 44.99% |
| Jan 31, 2023 | -38.72% |
| Oct 31, 2022 | 30.57% |
| Jul 31, 2022 | 28.21% |
| Apr 30, 2022 | -25.39% |
| Jan 31, 2022 | 38.56% |
| Oct 31, 2021 | -54.96% |
| Jul 31, 2021 | 12.82% |
| Oct 31, 2020 | -41.06% |